Fiche centre
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Rome — Italy
Essais liés5clinical trials
VilleRomelocalisation
PaysItalylocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07598396
Essais cliniques associés
5| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Inavolisib | Cancer | Phase 3 | NCT06790693 | INAVO123 — A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer | RECRUITING |
| CONTRASTOME — Human Amniotic Mesenchymal Cell Secretome for Neurodegeneration and Neuroinflammation | Sclérose latérale amyotrophique | Non applicable | NCT06551649 | CONTRASTOME — Human Amniotic Mesenchymal Cell Secretome for Neurodegeneration and Neuroinflammation | ACTIVE_NOT_RECRUITING |
| SGT-003 | Myopathies | Phase 1/2 | NCT06138639 | A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE) | RECRUITING |
| Mosunetuzumab | Lupus | Phase 2 | NCT07598396 | SOLUNA — A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis | RECRUITING |
| Telitacicept | Myasthénie | Phase 3 | NCT06456580 | A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG) | RECRUITING |